The development of novel theranostic agents for breast cancer imaging and treatment

QR Code

The development of novel theranostic agents for breast cancer imaging and treatment

Cancer is a disease that affects up to one in two people [1]. There are currently a wide variety of treatment options available but these are limited by toxic side effects such as myelosuppression and alopecia [2]. One new treatment option being developed is theranostics. Theranostics is a technique...

Full description

Bibliographic Details
Main Author:	Duthoit, Sophie
Format:	Thesis (University of Nottingham only)
Language:	English
Published:	2021
Subjects:	cancer treatments theranostics therapeutics
Online Access:	https://eprints.nottingham.ac.uk/66033/

Similar Items

Theranostic tools against lung and breast cancers : through the lens of mature gold nanoparticles and emerging graphene
by: Baskaran, Savuntherii, et al.
Published: (2024)

Novel multifunctional platinum nanodendrites as theranostic agents in cancer imaging and radiotherapy treatment
by: Anuar, Muhammad Afiq Khairil
Published: (2021)

Passerini multicomponent reaction: a versatile synthesis of nanomedicines for triple negative breast cancer treatment
by: Travanut, Alessandra
Published: (2021)

Apoptosis and cell cycle mechanisms of ampelopsin E on triple negative breast cancer cells
by: Abd Rahman, Napsiah
Published: (2017)

Characterization and anti-cancer effects of citral-loaded nanostructured lipid carrier in breast cancer cells in vitro and in vivo
by: Nordin, Noraini
Published: (2017)

Cytotoxic effects of 7-geranyloxycinnamic acid isolated from Melicope lunu-ankenda (Gaertn) T.G.Hartley leaves on breast cancer cell lines (MCF-7 and MDA-MB-231
by: Eliaser, Enas Mohamed Abdaallah
Published: (2022)

Evaluation of Newcastle disease virus as an oncolytic agent in colorectal cancer cell lines
by: Chia, Suet Lin
Published: (2012)

Antioxidant properties and cytotoxicity of successively macerated Christia vespertilionis (L.f) Bakh.f. root and leaf against breast cancer cell lines
by: Lee, Joanna Jinling
Published: (2020)

Effects of ampelopsin E towards the invasiveness of triple negative breast cancer cell line, MDA-MB-231
by: Tieng, Francis Yew Fu
Published: (2019)

Biological assessment - developing a novel tool to guide treatment decision in older women with primary breast cancer
by: Parks, Ruth M.
Published: (2023)

Docetaxel-loaded magnetic nanostructured lipid carrier functionalized with fish oil-coated iron oxide nanoparticles intended for lung cancer treatment
by: Idris, Auni Hamimi
Published: (2021)

Fabrication, characterization and functionalization of single-walled carbon nanotube conjugated with tamoxifen and its anticancer potential against human breast cancer cells
by: Oskoueian, Arshin
Published: (2018)

In Vitro Mass Propagation, Anti-Cancer Activity and Phytochemical Analysis of Typhonium Flagelliforme
by: Galehpardsari, Motahareh Nobakht
Published: (2009)

Microbiota profile of Malaysian kefir grain and anti-metastatic effects of kefir water in murine breast cancer cells
by: Zamberi, Nur Rizi
Published: (2016)

Characterization of dentatin isolated from Clausena excavate and its potential use for treatment of human breast and prostate cancers
by: Ishag, Ismail Adam Arbab
Published: (2012)

Light-Induced Cytochrome c Redox Mediated Cell Killing
by: Potts, Jordan Cameron
Published: (2023)

Development and characterization of docetaxel and curcumin-loaded aerosolized nanoemulsion for pulmonary cancer
by: Asmawi, Azren Aida
Published: (2020)

Assessment of risk factors and identification of potential biomarkers associated with breast cancer-related lymphedema in Malaysian breast cancer survivors
by: Md Yusof, Khairunnisa'
Published: (2022)

Polyadenylation as a target for the treatment of breast cancer
by: Thiyab, Asraa
Published: (2025)

Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer
by: Alexander, Angela, et al.
Published: (2017)

Biomedical application of OrbiSIMS in cancer: identification of anti-cancer agents and metabolite profiles
by: Lu, Yonghui
Published: (2023)

Effects of co-loaded doxorubicin and thymoquinone calcium carbonate nanoparticles on MDA MB231 breast cancer stem cells
by: Muibat, Ibiyeye Kehinde
Published: (2019)

The Management of Acute Adverse Effects of Breast Cancer Treatment in General Practice: A Video-Vignette Study
by: Jiwa, Moyez, et al.
Published: (2015)

Treatment strategies and survival outcomes in older women with breast cancer: a comparative study between the FOCUS cohort and Nottingham cohort
by: Schuil, Hugo, et al.
Published: (2018)

Curcumin containing chitosan-pectinate nanoparticulate drug delivery system for colon cancer treatment
by: Alkhader, Enas Ali
Published: (2018)

Development and Encapsulation of Affibody-Apoferritin Biologics for the Targeted Treatment of Breast Cancer
by: Holden, Isobel R
Published: (2025)

A new normal?: women's experiences of biographical disruption and liminality following treatment for early stage breast cancer
by: Trusson, Diane, et al.
Published: (2016)

Fabrication, characterization and evaluation of β-elemene nanoparticles for anti-cancer treatment
by: Zhao, Xi
Published: (2020)

An investigation into treatment administration and survival for people with small cell lung cancer
by: Jones, Gavin Stewart
Published: (2019)

A continuing mission to optimize the care of older women with breast cancer
by: Cheung, Kwok-Leung
Published: (2017)

Toxicity and anti-breast cancer properties of thymoquinone-loaded nanostructured lipid carrier in mice
by: Ong, Yong Sze
Published: (2019)

The Malay Muslim cancer patients’ perspectives on Islamic healing cancer treatment
by: Suhami, Norhasmilia
Published: (2014)

Development and characterization of a theranostic micelles system using TPGS with docetaxel and coumarin-6: a dual polymeric nanocarrier system
by: Ching, L.H., et al.
Published: (2018)

PIK3C Agene mutations in breast carcinoma in Malaysian patients
by: Leong, Vincent Ching-Shian, et al.
Published: (2008)

Factors surrounding treatment decisions in non-small cell lung cancer
by: Morgan, Helen
Published: (2024)

Genetically exceptional?: women's experiences of being at risk of hereditary breast and ovarian cancer
by: Rowley, Emma
Published: (2005)

Recent advances in the development of multifunctional lipid-based nanoparticles for co-delivery, combination treatment strategies, and theranostics in breast and lung cancer
by: Loo, Yan Shan, et al.
Published: (2022)

Novel strategies for inhibiting cancer growth
by: Schaefer, Rainer
Published: (2008)

Comparison Of Chemical Profiles Of Black Cumin Seed (Nigella Sativa .L) Extracts And Evaluation Of Their Cytotoxic Effect On Breast Cancer Mcf-7 And Mda-Mb- 231 Cell Lines
by: Ghahramanloo, Kourosh Hasanzadeh
Published: (2009)

Targeting ataxia telangiectasia-mutated and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized cancer therapy
by: Alsubhi, Nouf
Published: (2018)